4.6 Article

Rising incidence of early-onset colorectal cancer - a call to action

Journal

NATURE REVIEWS CLINICAL ONCOLOGY
Volume 18, Issue 4, Pages 230-243

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41571-020-00445-1

Keywords

-

Categories

Funding

  1. US NIH [R35 CA197735, R01 CA248857, R21 CA230873, R01 CA205406, R03 CA197879, R37 CA246175]
  2. Cancer Research UK Grand Challenge Award [UK C10674/A27140]
  3. Investigator Initiated Grant from the American Institute for Cancer Research (AICR)
  4. US Department of Defense grant [CA160344]
  5. Project P Fund
  6. Stand Up to Cancer Colorectal Cancer Dream Team Translational Research Grant [SU2C-AACR-DT22-17]
  7. Overseas Research Fellowship grant from the Japan Society for the Promotion of Science [201960541]
  8. Uehara Memorial Foundation
  9. Yasuda Medical Foundation
  10. Grant of The Clinical Research Promotion Foundation

Ask authors/readers for more resources

The global incidence of early-onset colorectal cancer is on the rise, potentially due to factors such as diet, obesity, lack of exercise, and antibiotic use. Early-onset CRC differs clinically, pathologically, and molecularly from later-onset CRC. Further research spanning childhood and young adulthood is necessary to enhance understanding and management of this disease.
The incidence of early-onset colorectal cancer (CRC), which occurs in individuals <50 years of age, has been increasing worldwide and particularly in high-income countries. The reasons for this increase remain unknown but plausible hypotheses include greater exposure to potential risk factors, such as a Western-style diet, obesity, physical inactivity and antibiotic use, especially during the early prenatal to adolescent periods of life. These exposures can not only cause genetic and epigenetic alterations in colorectal epithelial cells but also affect the gut microbiota and host immunity. Early-onset CRCs have differential clinical, pathological and molecular features compared with later-onset CRCs. Certain existing resources can be utilized to elucidate the aetiology of early-onset CRC and inform the development of effective prevention, early detection and therapeutic strategies; however, additional life-course cohort studies spanning childhood and young adulthood, integrated with prospective biospecimen collections, omics biomarker analyses and a molecular pathological epidemiology approach, are needed to better understand and manage this disease entity. In this Perspective, we summarize our current understanding of early-onset CRC and discuss how we should strategize future research to improve its prevention and clinical management. The incidence of early-onset colorectal cancer (CRC) is increasing worldwide for reasons that are currently unclear. Herein, the authors review the current epidemiological, clinical, pathological and molecular understanding of early-onset CRC that occurs in patients >= 50 years of age, drawing contrasts with later-onset CRC. They also discuss future research strategies for improved understanding, prevention, early detection and clinical management of early-onset CRC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available